Recombinant Pseudomonas Exotoxins

Company
Bristol-Myers Squibb Company
Use
Used to target the Lewis-Y antigen for therapeutic and diagnostic purposes
Features
The first active immunotoxin with low side effects
NIH Contribution
Developed the recombinant pseudomonas exotoxin
HHS Institute/Agency
NCI
Inventor(s)
I. Pastan, D. Fitzgerald
Year
1996
Tech Cat
Research Reagent

Request More Info

L-326-1991